President Joe Biden has for several months opposed the move from the withdrawal of the patent and has received numerous pressures from Ejecutivo.Debido the current situation, the US Government has changed its mind: In India and South America, the number of infections has increased considerably and the inequalities in dealing with the pandemic are becoming increasingly apparent. On Wednesday afternoon, the government issued a communiqué calling for the temporary liberalization of patents with the aim of accelerating global vaccination.
The US representative of the World Trade Organization, Katherin Tai, has stated that the Government believes in patents but "the exceptional situation of the pandemic requires exceptional measures."
Last October, India and South Africa asked the World Trade Organization (WTO) for the temporary withdrawal of vaccine patents, which were joined by countries in Latin America, Africa and Asia. It was intended that vaccine production should not be dependent on pharmaceutical companies and that vaccination campaigns should be speeded up in order to control the pandemic. But the United States opposed it.
From now on, negotiations for the provisional withdrawal of copyright from vaccines will begin and, according to Tai, “they will need time.” The withdrawal of the patent is only the starting point. The africketic industry should also facilitate so-called “transfer technology”, as they should provide the knowledge of the production and dose preservation process. The pharmaceutical sector has been against it and has said that it will create "problems" and that it will "slow down the process of vaccine generation".
The President of the European Commission, Ursula von der Leyen, said that she was "prepared" to discuss the exemption from the withdrawal of the patent and would urge the producer countries to "dismantle export measures and hamper supply chains".
It expressed its desire to reverse the situation and added that the European Commission "is ready to discuss any proposal that can effectively and pragmatically address the crisis".
Janssen farmazia multinazioanalak txertoaren ikerketa bertan behera uzteko erabakia hartu du, batzorde batek ondorioztatu ostean txertoak ez dituela giza immunoeskasiaren birusari aurre egiteko baldintzak betetzen.
Farmazia enpresa alemaniarrak hamar mila milioi euro irabazi ditu Covid-19aren aurkako txertoen patenteei esker. Hainbat ikerketak frogatu dute farmazeutiken lobbyek oztopatu dituztela patenteak askatzeko akordioak. BioNTechek sare sozialetako mezuak zentsuratu nahi izan ditu,... [+]
COVID-19 kasuek gora egin dute Europan eta 60 eta 79 urte artekoei eta gaitza larri pasatzeko arrisku handiagoa dutenei txertoaren laugarren dosia “berehala” jartzea gomendatu dute Sendagaien Europako Agentziak (EMA) eta Gaixotasunen Prebentziorako eta Kontrolerako... [+]
Erresuma Batuko Airfinity datu analizatzaileak aurreikusi du Europar Batasunak eta G7ko estatuek erositako milioika txerto dosi xahutuko direla erabili aurretik; ohartarazi dute banaketa arazoengatik izan litekeela. UNICEFek jakinarazi du herrialde pobretuek uko egin zietela 100... [+]
Nafarroako Osasun Publikoaren eta Lan Osasunaren Institutuaren azken txostenaren arabera, COVID-19ak eragindako heriotza kopurua oraingoaren bikoitza izango litzateke, haren kontrako txertoaren kanpaina martxan jarri ez balitz.
Many of the decisions of this pandemic need transparent, free and in-depth discussions. We should discuss infant vaccination against COVID-19, as the work on this Seminar on Innovation in Primary Care (SIAP) and the Spanish Network of Primary Care (REAP) have made clear.
The... [+]
Patenteetatik libre dagoen COVID-19aren aurkako txerto berri bat sortu du Texasko haurrentzako ospitaleko txertoen garapenerako zentroak (AEB). Indiak dagoeneko onartu du txerto hori erabiltzeko emergentziazko baimena eta haren sortzaileek espero dute laster Indonesian,... [+]
COVID-19ari dagokionez, abenduaren 22an hasi dute umeei zuzenduriko "hautuzko txertaketa" Ipar Euskal Herrian. Desadostasunak eta ulertu ezinak areagotzen ditu azken neurri honek.
Ayoade Alakija Afrikako Batasuneko presidentekideak salatu du omikron aldaera txertoen banaketa desorekatuaren ondorioz sortu dela. Bestalde, EMAk bosgarren txertoaren merkaturatzea onetsi du, “eraginkorra, kalitatezkoa eta segurua” dela baieztatuta; oraindik ez... [+]